Oct 9, 2024 · FDA approves two new COPD treatments in 2024 Verona Pharma’s Ohtuvayre. In June 2024, the FDA approved the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. The product, called Ohtuvayre (ensifentrine), was developed by Verona Pharma – a London-based company established 19 years ago to unlock the potential of ...

Visit our 2025 biotech funding tracker for the newest funding rounds!. Discover the latest in biotech funding on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the cutting-edge trends and investments driving the industry forward.

January 2025:. 22-23 January 2025: Paris, France – Pharmapack 28-30 January 2025: Frankfurt, Germany – mRNA-based Therapeutics Summit 29-30 January 2025: London, UK – Festival of Genomics and Biodata; February 2025: 4 February 2025: Zurich, Switzerland – Zurich Life Science Day 2025; 6-8 February 2025: Strasbourg, France – 7th European CAR T-cell Meeting

Jan 2, 2025 · GSK goes big in December 2024 with licensing deals. Among GSK’s latest conquests is nabbing the licensing rights to DB-1324, an antibody-drug conjugate (ADC) from Chinese biotech Duality Biologics.

Oct 24, 2024 · Biogen Leading multiple sclerosis drug candidate of Biogen: BIIB091 . Biogen is known for its pioneering work in the neuroscience field.It has been discovering and developing treatments for CNS disorders for more than 40 years, including treatments for multiple sclerosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, depression, lupus, and …

January 2024: AbbVie and Umoja Biopharma, both based in the United States, are partnering to develop novel in-situ CAR-T cell therapies. Umoja is eligible to receive up to $1.44 billion for option exercise fees, development, and regulatory milestones.

Jun 20, 2024 · The CasMINI protein is engineered to function effectively in cells and is small enough to be delivered in vivo using AAV vectors. This compact size and robust functionality make it possible to target a wide range of tissues and organs with high precision. Epic Bio’s pipeline is still preclinical and targets a wide variety of diseases.

Biotech associations play a crucial role in advancing the industry by connecting biotech companies, pharmaceutical firms, academic institutions, research organizations, policymakers, and investors.

Sep 19, 2024 · The immunology field has recently become one of the hottest areas in the biopharma industry, attracting a major wave of investment over the past couple of years. In fact, there have already been more than 10 buyouts of immunology and inflammation (I&I) drug developers this year from some of the biggest names in pharma and biotech, and multiple immunology companies have recently launched and ...

4 days ago · Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!